retatrutide weight loss trial retatrutide This data from Phase 3 clinical trials for was announced yesterday at @amdiabetesassn #ADA2026 ✓ We are fortunate to be living in a time where there multiple medications which safely reduce Medscape | Retatrutide, Eli Lilly's

Description

GLP-1 MEDICATIONS There are currently two classes of GLP-1 receptor agonists available for weight loss: semaglutide and tirzepatide

Semaglutide works by mimicking the GLP-1 hormone that signals fullness to the brain

Alcoholic Beverages Alcohol may increase the risk of nausea, bloating, and blood sugar fluctuations

For appropriately selected patients, they can produce meaningful weight loss, improve diabetes management, lower cardiovascular risk, and enhance overall metabolic health

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of injectable medications used primarily for managing type 2 diabetes and, in some formulations, for weight management